Yasmin Post Marketing Surveillance

Bayer

Status: Completed

Conditions: Contraception

Treatments: Drug: EE30/DRSP (Yasmin, BAY86-5131)

Study type: Observational

Funder types: Industry

Identifiers

NCT00923572

YA0510KR (Other Identifier)

14339

Details and patient eligibility

About

The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.

Enrollment: 777 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women who need oral contraceptive

Exclusion criteria

• Patient who belongs to contraindication listed on the product label.

Trial design

777 participants in 1 patient group

Group 1

Treatment:

Drug: EE30/DRSP (Yasmin, BAY86-5131)